Delivery Order SPE2DE24D0013-SPE2D626F091K
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $4,080 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. The delivery order, designated 4569971783 and titled XPCOV2/FLU/RSV-10, procures diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 delivery order (4569923616) by the Defense Logistics Agency Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The contract is for XPCOV2/FLU/RSV-10 diagnostic products—molecular testing reagents and cartridges for detecting COVID-19, influenza, and respiratory syncytial virus on the GeneXpert diagnostic platform. This is a firm fixed-price delivery order with no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,270.50 by the Defense Logistics Agency's Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 19, 2025. The delivery order, designated XPRSARS-COV2-10, is issued under a firm fixed-price contract structure with no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F091KDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $4,198.65 firm fixed-price delivery order (Contract No. 4569971781) from the Defense Logistics Agency Medical Supply Chain on November 10, 2025, for respiratory pathogen diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order is scheduled for completion by November 18, 2025, and carries no set-aside designation. The award represents procurement through the Defense Logistics Agency's medical supply chain operations, which support diagnostic testing capabilities across the Department of Defense and federal healthcare systems. This delivery order reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions, particularly for respiratory pathogen detection. The company maintains extensive federal contracting relationships across multiple agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, with contract values ranging from modest service orders to multi-million dollar indefinite delivery vehicles. Cepheid's GeneXpert diagnostic platform and associated molecular testing capabilities have positioned the company as a critical vendor for federal agencies requiring rapid, accurate infectious disease testing across military medical centers, VA facilities, and tribal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/10/25 |